regularly tries cases in federal courts and before arbitration panels and has argued before the Court of Appeals for the Federal Circuit. Her cases have involved diverse technological fields such as recombinant antibodies, medical devices and methods, pharmaceuticals and semiconductor wafer processing.
In addition to representing clients in litigation and arbitration proceedings, Ms. Mullin also counsels innovator pharmaceutical and medical device clients on strategic patenting and licensing issues and freedom to operate, as well as Orange Book Listings, Paragraph IV certifications and other ANDA-related matters.
Ms. Mullin’s recent and representative litigation experience includes—
- serving as one of the principal attorneys representing Centocor Ortho Biotech and New York University in a patent trial charging Abbott Laboratories’ Humira® product with infringement. The jury returned a verdict that Ms. Mullin’s clients’ patent was willfully infringed and not invalid, and awarded damages of $1.67 billion. The verdict was reported by Bloomberg to be the largest jury verdict in U.S. history in a patent case.
- successfully defending The Ohio Art Company in patent infringement suit by Larami Limited alleging infringement of two SuperSoaker® patents
- serving as one of the principal attorneys in a Northern District of California jury trial, successfully representing a large computer-chip manufacturing equipment company asserting its process and apparatus patents. The case settled after trial, with Ms. Mullin’s client receiving more than $70 million in past damages and ongoing royalties.
- obtaining a preliminary injunction followed by a favorable decision at trial and an award of attorneys’ fees on behalf of the plaintiff in LifeScan Inc. v. Polymer Technology International
- serving as one of the principal attorneys in obtaining favorable arbitration ruling on the merits and an award of attorneys’ fees and costs on behalf of the plaintiff in LifeScan v. Diagnostic Solutions, Inc.
Ms. Mullin is a frequent speaker on topics relating to patent litigation. Her recent speaking engagements include—
- "Formulating Patent Litigation Strategies to Prevail in the Face of Evolving Case Law, " American Conference Institute Advanced Forum on Biotech Patents
- "A View from the Bench: Concurrent PTO Proceedings," Practising Law Institute Reissue and Reexamination Strategies and Tactics with Concurrent Litigation
- "Ethical Considerations of Reissue, Ex Parte and Inter Partes Reexamination Proceedings," Practising Law Institute Reissue and Reexamination Strategies and Tactics with Concurrent Litigation
Ms. Mullin received her J.D. cum laude
in 1991 from Villanova University School of Law and served on Law Review. She received her B.S. cum laude from the University of Pennsylvania in 1985.
For the past few years, Ms. Mullin has been recognized as among the top 5 percent of attorneys in Pennsylvania based on a survey of her peers and a blue ribbon panel review. She was also recently honored by being selected and admitted as a fellow in the Litigation Counsel of America, a trial honorary society for litigation and trial counsel across all segments of the bar. Ms. Mullin has also been recognized by The Best Lawyers in America as a leading practitioner in the area of patent litigation.
Ms. Mullin supports several pro bono activities, including the Support Center for Child Advocates and the Equal Access to Justice Campaign of the Philadelphia Bar Foundation.